MedPath

Comparison of effect,safety and cost of sertaconazole cream versus luliconazole cream in patients with dermatophytoses

Phase 4
Completed
Conditions
Health Condition 1: null- DERMATOPHYTOSES PATIENTSHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2017/11/010418
Lead Sponsor
Government Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
59
Inclusion Criteria

1)Adults between the age group of 18 to 70 years of either gender, with clinical diagnosis and mycological confirmation (positive KOH test) for tinea corporis and tinea cruris infections, will be included in the study.

2)Patient having a Physician global assessment (PGA) composite score of at least 5 will be included in the study.

3)Patient willing to give written informed consent will be included in the study

Exclusion Criteria

1)Patients having clinical diagnosis of tinea infections other than tinea corporis and tinea cruris,

2)Patients having extensive fungal infection,

3)Patients who had received topical or oral antifungal agents upto four weeks prior to the initiation of the study,

4)History of hypersensitivity to study drugs,

5)Immunocompromised patients,

6)Patients having superadded bacterial infection,

7)Pregnant or lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.